Summary
Overview
Work History
Education
Skills
Affiliations
Areas Of Research Interest
Certification
Invited Lectures
Scientific Committees
Grandchildren
Spouse
Honors And Awards
Personal Information
Timeline
Generic
Peter L. Nara

Peter L. Nara

Senecaville,USA

Summary

Co-founder of multiple biotech companies with leadership roles as CEO and CSO, driving innovation in biologics. Developed effective strategies for cancer treatments and vaccines, focusing on AI integration and genomic target identification. Achievements include securing significant funding and managing regulatory processes, resulting in enhanced operational efficiency and scientific advancements.

Overview

1
1
Certification
39
39
years of professional experience

Work History

Co-founder/CSO/VP BD

Keystone Bio Inc.
01.2017 - Current

Professor, Microbiology/Infectious Diseases

Caver College of Medicine, University of Iowa
Iowa City, Iowa
01.2009 - Current

Expert Consultant in Biotechnology, Infectious Diseases, Vaccinology, Comparative Medicine, Animal Models, Pre-clinical Pharmaceutical development, Cancer biology, Immunology

Gerson Lehrman Group Inc.
New York, New York
01.2008 - Current

Cofounder, President, Chief Executive Officer

Biological Mimetics, Inc.
Frederick, Maryland
01.2004 - Current

Co-founder, Senior Business Advisor, CSO/CTO and Board member

Keystone Bio Inc.
St. Louis, Mo
01.2018 - 01.2024

Co-founder, Business Development, Senior technical and medical Advisor

Lantern Pharma
Dallas, Texas
01.2013 - 01.2018
  • Led founding and development of business strategy, created investor documents and pitches, facilitated fundraising, installed junior and senior executives, managed R&D wet lab operations, and coordinated scientific developments linking targetable cancer genomic markers to an innovative AI platform integrating drug libraries.
  • Secured TIE 50 award from Silicon Valley, drafted provisional patents, defended patent prosecution at USPTO, and managed pre-IND and IND regulatory communications and filings, including in- and out-licensing agreements.
  • Https://www.lanternpharma.com/pharma.com

Co-founder, President, and Chief Executive Officer of Chairman Emeritus

Biological Mimetics Inc.
Frederick, Maryland
01.1997 - 01.2018

Lead Expert Witness Pharmaceutical Vaccine Products Lawsuit

Quinn Emanuel Urquhart & Sullivan, LLP
New York, New York
01.2013 - 01.2014

Professor-Department of Biomedical Sciences-joint appoints in: Immunobiology and Veterinary Microbiology and Preventative Medicine

Iowa State University
Ames, Iowa
01.2008 - 01.2013

Cofounder, Executive Vice President, Chief Scientific Officer

Biological Mimetics, Inc.
Frederick, Maryland
01.1997 - 01.2004

Chief, Vaccine Resistant Diseases Section, LBS, and Division of Basic Sciences

National Cancer Institute
Frederick, Maryland
01.1988 - 01.1997

Education

Comparative Pathology Residency -

Armed Forces Institute of Pathology-Comparative Pathology Division
Washington, D.C.
01-1988

Ph.D. - Veterinary Medicine, Department of Veterinary Pathobiology

The Ohio State University
Columbus
01-1986

D.V.M. - College of Veterinary Medicine

The Ohio State University
Columbus
01-1984

M.Sc. - Veterinary Medicine, Department of Veterinary Physiology and Pharmacology, and Veterinary Pathobiology

The Ohio State University
Columbus
01-1979

B.S. -

Colorado State University
Ft. Collins
01-1977

Skills

  • Regulatory compliance
  • Clinical trial management
  • Project management
  • Strategic partnerships
  • Fundraising strategy management
  • Market research
  • Data analysis

Affiliations

  • The American Association of Veterinary Immunologists, 1979
  • The American Association of Veterinary Laboratory Diagnosticians, 1980
  • The American College of Veterinary Physiologists and Pharmacologists, 1980
  • The American Veterinary Medical Association, 1984
  • The National Geographic Society, 1986
  • Charles Louis Davis, D.V.M., Foundation for the Advancement of Veterinary Pathology, 1987
  • Scientific Research Society, Sigma Xi, 1990
  • American Society for Microbiology, 1992
  • International Society for Vaccines, 1993
  • American Association for the Advancement of Science (AAAS), 2007

Areas Of Research Interest

  • Discovering new and novel mechanism(s) of virulence, pathogenesis and host adaptation to infectious diseases and cancer to develop prophylactic and or early interventive treatments and diagnostics
  • Developing novel immunobiotics and classes of vaccines infectious diseases of humans and animals
  • Comparative basic and clinical Microbiology
  • Virology (RNA)
  • Comparative Medicine
  • Comparative Oncology
  • Comparative Pathology
  • Comparative Immunology
  • Vaccinology
  • One Medicine/Health
  • Host/pathogen evolution
  • Evasion of Immunity
  • Fundamentals of Systems Biology
  • Biophysics/quantum biology

Certification

  • Doctor of Veterinary Medicine, Ohio, 5326, 01/01/84, present
  • Federally Accredited Veterinarian, United States Department of Agriculture, 01/01/84, present
  • Doctor of Veterinary Medicine and Surgery, Maryland, 3189, 01/01/87, present
  • Foreign Animal Disease First Response Unit-Trained Situation Commander/Trainer, Maryland Department of Agriculture, 01/01/11, present
  • Maryland Medical Reserves Corps., Disaster and Emergency Response Unit, Frederick, Maryland, 01/01/12, present

Invited Lectures

  • 10/01/90, Collaborating Reference Laboratory for the Annual NIAID Serologic Panel
  • 12/01/91, Designated a World Health Organization (WHO) sanctioned HIV reference laboratory
  • 03/01/92, Howard Hughes invited lecturer, 'AIDS a Pandemic Plague for the 90's: A look at the virus, host and the scientific process of medical intervention', Ohio Wesleyan University
  • 01/01/95, Appointed, Professor of Research Hood College, Biomedical Science Department/Program
  • 03/01/95, Plenary Speaker and Chairman, 3rd Annual Vaccines: New Technologies and Applications, Washington, DC
  • 03/01/95, Invited Plenary Speaker for the 3rd National Congress on AIDS, La Corona, Spain
  • 03/01/95, Invited Speaker and Session Chairman, 1st International Symposium on Cytokine/HIV-1 Reims, France
  • 04/01/95, Distinguished Miles Guest Lecturer in Series on Advances in Immunobiology, Department of Microbiology, Washington State University
  • 07/01/95, Invited special lecturer, Ciba Corning 'Issues in Immunodiagnostics' Infectious Diseases: The Threat and Future Strategies, Anaheim, CA
  • 09/01/95, Invited Lecture/Chairman for the 4th Workshop on Viral Resistance, Annapolis, MD
  • 01/01/96, Invited Lecturer/Chairman for the 3rd HIV Immune-Based Therapies Workshop, Clinical Immunology Society, Washington, DC
  • 05/01/96, Plenary speaker and panelist, for the National Consortium for Genomic Resources Management and Services, McLean, VA
  • 07/01/96, Chairman, Humoral Responses to HIV-1, XI International AIDS Conference, Vancouver, BC
  • 04/01/97, Invited Lecturer for the Drug Information Association 'Current Aspects of Vaccinology and Molecular Virology, Laguna Cliffs, Dana Point, California
  • 07/01/97, Plenary Lecturer, First International Veterinary Vaccines and Diagnostics Conference, Madison, Wisconsin, USA
  • 09/01/97, Chairman, invited speaker, and panelist, An International Meeting on HIV and Immunoregulation, Portmerion Village, Porthmadog, North Wales
  • 09/01/97, Conference organizer, Chairman and Speaker, First Symposium on Vaccinology, Xerox Conference Center, Leesburg, VA
  • 04/01/98, Invited Conference Co-chair, Speaker and Panelist, New Technologies and Applications of Vaccines, PGA National Resort
  • 06/01/98, Conference Organizer, co-chair, speaker and panelist, The First Annual Conference on Vaccine Research, sponsored by the National Foundation for Infectious Diseases, Center for Disease Control, National Institute of Allergy and Infectious Diseases and The International Society for Vaccines, Wash. D.C.
  • 10/01/00, Conference Session Chair and invited speaker. New Paradigms in Infectious Disease: Applications to Otitis Media, Pittsburgh Marriott City Center, Pennsylvania
  • 05/01/01, Conference Organizer, co-chair, speaker and panelist, The Third Annual Conference on Vaccine Research, sponsored by the National Foundation for Infectious Diseases, Wash. D.C.
  • 05/01/03, Symposium Speaker, Conference Co-chair, Scientific Program committee, 6th Annual Conference on Vaccine Research, Crystal City, Arlington VA
  • 08/01/05, Member and Immunology Vaccine expert consultant Field Trip participant- Expert Immunology consultant for the United States Animal Health Association Brucellosis Vaccine & Diagnostic Workshop, Laramie, Wyoming
  • 05/01/06, Symposium Speaker, Conference Co-chair, Scientific Program committee, 9th Annual Conference on Vaccine Research, Inner Harbor Baltimore Maryland
  • 06/01/06, Invited speaker for UCLA AIDS symposium, Los Angeles. CA
  • 06/01/06, Association of American College of Veterinary Medical Colleges Plenary Speaker and Board member 'The Foresight Project-The Future of Veterinary Medicine in the United States and World. 2006.
  • 07/01/06, Plenary Speaker, The 10th International Society for Developmental and Comparative Immunology- Charleston, South Carolina 2006
  • 08/01/06, 16th International AIDS Meeting Toronto, Canada
  • 08/01/06, Invited Session speaker-'Targeted Immunotherapeutics and Vaccine Summit', Cambridge Mass.
  • 10/01/06, Invited Expert committee member and speaker; 'Chimpanzees in Research: A Vital Resource for Medical Advancements'. Yerkes Primate Research Center, Emory University, Atlanta Ga.
  • 12/01/06, Keynote Speaker International PRRS symposium, Conference of Research Workers in Animal Diseases (CRWAD).
  • 03/01/07, Invited consultant for the U. of Penn. The Wharten School and Artesy Institute of Executive Education and School of Business Leadership Development Program in Professional Veterinary Medicine, Philadelphia, PA.
  • 08/01/07, Invited speaker for BIO IT Coalition Maryland. New platform technologies in Immunobiotic development for human and animal health, Rockville, MD.
  • 09/01/07, Featured Guest Speaker on the weekly Washington Business Radio Talk show 'Tomorrow's Business and Pepper Moments' hosted by Steve Mandell.
  • 11/01/07, Awarded the Congressional Order of Merit, Senator Tom Cole
  • 12/01/07, Plenary Speaker- 25th anniversary Vaccine Congress, Amsterdam, The Netherlands, Dec. 9-11, 2007.
  • 09/01/08, Featured Guest Speaker on the weekly Washington Business Radio Talk show 'Tomorrow's Business and Pepper Moments' hosted by Steve Mandell.
  • 02/01/08, Selection to the Reagan Congressional Economic Commission State of Maryland
  • 06/01/08, Speaker-State Department Sponsored International Workshop on Brucellosis as a Transboundary Infection of Animal and Humans which needs to be managed by cooperative efforts with different countries, Serpuukov, Russia
  • 09/01/08, Invited lecturer Iowa Biotechnology Association- 'Introduction the Center for Advanced Host Defense, Immunobiotics and Translational Comparative Medicine -CAHDIT-An Interdisciplinary Approach to Address Global Health Challenges', Ames Iowa
  • 10/01/08, Mayo Clinic Visiting Professor Lectureship, Rochester, MN.
  • 10/01/08, Invited lecturer and finalist for the 2nd World Ehrlich II Conference on Magic Bullets Nierenberg, Germany.
  • 12/01/08, Plenary lecturer 2nd Global Congress Elsevier Vaccine Meeting, Boston, Mass.
  • 01/01/09, Plenary lecturer Designing Antibody and Protein Therapeutics, PEP Talk, San Diego, California.
  • 02/01/09, Plenary Lecture International Conference on Current Trends in Biotechnology and implications in Agriculture, Sardar Vallabh Bhai Patel University of Agriculture and Technology, Modipuram, Meerut India.
  • 02/01/09, Lecturer University of Calcutta, Scholl of Biotechnology: Future of Biotechnology in the vaccine arena. Calcutta, India.
  • 04/01/09, Keynote lecture 3rd Annual Vaccines Summit Asia -'Deceptive Imprinting and vaccine design', Singapore, Singapore.
  • 04/01/09, Invited Lecturer National Shang hai Veterinary research institute-Center for Agriculture and Animal Science, Shang hai, China.
  • 05/01/09, Keynote Lecture 3rd Annual ISU Vaccines, Immunity and Wellbeing Symposium: The End of the Jennerian and Therapeutic Era in medicine? New Insights: from Deceptive Imprinting to Creating New Partnerships in Prevention Sciences for Sustainable Healthcare, Ames, Iowa.
  • 06/01/09, Invited Plenary Lecturer at the 8th Elsinore Meeting on Infection Immunity Statens Serum Institute, Copenhagen, Denmark.
  • 07/01/09, Invited Keynote lecturer Des Moines University School of Osteopathic Medicine Summer Scholar Research Symposium- 'The End of the Jennerian and Therapeutic era in medicine? New insights: from Deceptive Imprinting to creating new partnerships in prevention sciences', Des Moines, Iowa.
  • 11/01/09, Invited Keynote Lecture 'Deceptive Imprinting: The Next Major Decade in Systems Immunobiology.' Donahue Auditorium, Gordon Science Center, ASA Gray Biological Society, Utica College, New York.
  • 08/01/10, Keynote invited lecture- 'Perspectives on advancing preventative medicine through vaccinology at the comparative veterinary, human and conservation medicine interface: not missing the opportunities' American Chemical Society and The Industrial Bio-based Technology Subdivision of ACS Fall 2010 National Meeting & Exposition----ACS IBT Boston Fall Symposium 2010, Boston, Massachusetts, USA.
  • 10/01/10, 4th Vaccine and Annual ISV Congress, New Insights from In vitro and human infections with Human Rhinovirus, Vienna, Austria.
  • 11/01/10, Keynote: The 21st century of medicine: One medicine, one health, one science. Modern Veterinary Vaccines & Adjuvants MVVA 2010 17-19 November 2010 Sofitel Budapest Chain Bridge, Budapest, Hungary.
  • 11/01/11, Keynote Address. International Conference and Exhibition on Vaccines and Vaccination. Nov. 22-24. Philadelphia, Penn.
  • 11/01/11, Chemical and Biological Defense Science and Technology (CBD S&T) Conference. Inner Armor for the Soldier and Homeland Security, Las Vegas, Nevada.
  • 11/01/11, Keynote Address International Conference and Exhibition on Vaccines & Vaccination 22-24 Nov 2011 November 2010 - Omics Publishing meeting Group, Philadelphia Airport Marriott, USA.
  • 03/01/12, Keynote Dinner Speaker NCV Annual FLYSWAT Virology Retreat Sponsored by the Nebraska Center for Virology University of Nebraska-Lincoln, The Lied Lodge & Conference Center Arbor Day Farm, Nebraska City, NE.
  • 06/01/13, Keynote address: International Symposium on Molecular Medicine & Infectious Disease, Drexel College of Medicine, Institute for Molecular Medicine & Infectious Diseases, Philadelphia, PA.
  • 08/01/13, Keynote Address The 3rd International Conference on Vaccines & Vaccination, hosted by the OMICS Group July 29-31, 2013 at Embassy Suites Las Vegas, USA.
  • 10/01/13, Invited Seminar Series Speaker, Department of Veterinary and Microbiology Sciences, College of Veterinary Medicine, North Dakota State University, Fargo ND.
  • 02/01/14, Invited Guest Lecturer Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland.
  • 05/01/14, Invited Lecturer Center for Retrovirus Research, The Ohio State University Columbus, Ohio.
  • 05/01/14, Keynote Address Frontiers in Biomedical Research, Center for Protease Research, North Dakota State University, Fargo, ND.
  • 04/01/15, Joint International Lyme and Associated Diseases Society Meeting and Drexel College of Medicine- Tick-Borne and Other Chronic Infections, Research and Practice. Drexel University College of Medicine, Philadelphia, PA April 10 - 11, 2015.
  • 12/01/19, Microbiome Movement Gut Brain Axis, Boston MA.
  • 11/01/20, 5th United Scientific Group Vaccines R & D Newton MA.
  • 06/01/20, Microbiome Connect Human USA Virtual Summit Boston MA.
  • 04/01/21, 4th SACHS Annual Neuroscience Innovation Forum 2021. Digital Conference.
  • 07/01/21, Alzheimer's Association AAIC 2021, Denver CO.

Scientific Committees

  • Representative, National Cancer Institute for the Public Health Service AIDS Animal Model Committee, 12/01/87, 12/31/96
  • Representative, National Cancer Institute on the National Institute of Health's AIDS Scientific Vaccine Development Committee, 12/01/87, 12/31/96
  • Member, Center for Disease Control Simian Immunodeficiency Virus Biosafety Working Committee, 02/25/86, present
  • Ad Hoc Expert, Study Section Reviewer for AIDS/SAIDS grants, 03/28/88, 03/29/88
  • Member, National Cancer Institutes on the Public Health Service, AIDS Vaccine Task Force; Chairman of Animal Models Subgroup Committee, 03/21/88, 04/25/88
  • Member, National Cancer Institute - Office of the Director AIDS Task Force, 06/01/88, 09/30/90
  • Member, Vaccines Workgroup, 2nd Public Health Service, AIDS Prevention and Control Meeting, 06/01/88, 06/03/88
  • Member, Biology, Transmission and History Group, The National Scientific Effort on AIDS Modeling and Epidemiology, 07/25/88, 07/29/88
  • Member, World Health Organization (WHO) Workshop on the Standardization of Measurement of Neutralizing Antibodies to HIV

Grandchildren

  • Cayden Marie, 21
  • Zachery, 16
  • Logan, 15
  • Josephine, 13
  • Jase Peter Charles Lusiak, 10

Spouse

Brenda M. Davis/Nara, 1979

Honors And Awards

  • Recipient of Fort Dodge Honors Undergraduate Fellowship, 1976
  • Recipient of the Ohio Canine Grant Award, 06/01/78
  • Recipient of Outstanding Young Men of America, 05/01/80
  • Recipient of the National Cancer Institute Summer Training Award, 06/01/83
  • Recipient of the Ohio State University College of Veterinary Medicine's 'Excellence in Research Award', 05/01/84
  • Recipient of the National Cancer Institute, Post-Doctoral Medical Staff Fellowship, 06/01/84
  • Nominated Member of Who's Who in Veterinary Science and Medicine, 04/01/87
  • Howard Hughes Lecturer, 03/01/92
  • Tenured Veterinary Medical Officer/Scientist, National Cancer Institute Frederick Cancer Research Facility, 10/01/93
  • Nominated and elected as the first president of the International Society for Vaccines, 03/01/94
  • Miles Lecturer, 04/01/95
  • Recipient of the 1997 Federal Technology Transfer Act Award National Institutes of Health, National Cancer Institute, 10/01/97
  • Nominated Frederick County Business Entrepreneur of the year, 10/01/04
  • Congressional Medal/Order of Merit- Senator Tom Cole (Okla.), 10/01/07
  • 'Small Business firm of the Year' -finalist, State of Maryland Technology Council, 05/01/08
  • The W. Eugene Lloyd Endowed Entrepreneurial Chair Medallion, College of Veterinary Medicine, Iowa State University, 06/01/08
  • Elected as a 2011 AAAS Fellow, 12/01/11
  • Nominated Institute of Medicine Fellow, 01/01/14
  • Received The Distinguished Alumni Award from The Ohio State University and the College of Veterinary Medicine, 05/01/14
  • International Society of Vaccines Vaccinology Fellow of the month, 05/01/15
  • Recipient of the The Annual Indus Entrepreneurs (TiE) Top 50, 04/01/18
  • Awarded IFHA top 100 healthcare leaders medal, 07/01/21
  • Forsyth Dentech Start-up biotech company Competition Winner, 10/01/22
  • Microbiome Connect Preclinical Showcase winner, 11/01/23

Personal Information

  • Child Name: DeAnna Marie
  • Child Name: Kelly Ann
  • Child Name: Stephanie Lee
  • Child Name: Jessee Rachelle

Timeline

Co-founder, Senior Business Advisor, CSO/CTO and Board member

Keystone Bio Inc.
01.2018 - 01.2024

Co-founder/CSO/VP BD

Keystone Bio Inc.
01.2017 - Current

Co-founder, Business Development, Senior technical and medical Advisor

Lantern Pharma
01.2013 - 01.2018

Lead Expert Witness Pharmaceutical Vaccine Products Lawsuit

Quinn Emanuel Urquhart & Sullivan, LLP
01.2013 - 01.2014

Professor, Microbiology/Infectious Diseases

Caver College of Medicine, University of Iowa
01.2009 - Current

Expert Consultant in Biotechnology, Infectious Diseases, Vaccinology, Comparative Medicine, Animal Models, Pre-clinical Pharmaceutical development, Cancer biology, Immunology

Gerson Lehrman Group Inc.
01.2008 - Current

Professor-Department of Biomedical Sciences-joint appoints in: Immunobiology and Veterinary Microbiology and Preventative Medicine

Iowa State University
01.2008 - 01.2013

Cofounder, President, Chief Executive Officer

Biological Mimetics, Inc.
01.2004 - Current

Co-founder, President, and Chief Executive Officer of Chairman Emeritus

Biological Mimetics Inc.
01.1997 - 01.2018

Cofounder, Executive Vice President, Chief Scientific Officer

Biological Mimetics, Inc.
01.1997 - 01.2004

Chief, Vaccine Resistant Diseases Section, LBS, and Division of Basic Sciences

National Cancer Institute
01.1988 - 01.1997

Comparative Pathology Residency -

Armed Forces Institute of Pathology-Comparative Pathology Division

Ph.D. - Veterinary Medicine, Department of Veterinary Pathobiology

The Ohio State University

D.V.M. - College of Veterinary Medicine

The Ohio State University

M.Sc. - Veterinary Medicine, Department of Veterinary Physiology and Pharmacology, and Veterinary Pathobiology

The Ohio State University

B.S. -

Colorado State University
Peter L. Nara